Development and validation of a clinical prediction model for sepsis-induced cardiomyopathy
Frontiers in Cardiovascular Medicine · 17.07.2026 · 13
DOI: 10.3389/fcvm.2026.1788162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 17.07.2026. Verfasst von Tenghao Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Affiliated Hospital of Hebei University, Baoding City, China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Objective
The objective of this study was to develop and validate a clinically applicable risk-prediction model for sepsis-induced cardiomyopathy (SICM) and to evaluate its predictive performance comprehensively.
Methods
A retrospective cohort study was conducted using clinical data from patients with sepsis, obtained from the Medical Information Mart for Intensive Care IV database. Propensity score matching was applied to minimize confounding and achieve balance in baseline characteristics between groups. Candidate predictors were initially screened using univariate analysis, and feature selection was performed using the least absolute shrinkage and selection operator regression method. A multivariate logistic regression model was subsequently developed and externally validated with an independent dataset.
Results
The prediction model was derived from 956 patients and externally validated in a cohort of 104 patients. Five independent predictors were retained in the final model: serum phosphate concentration, neutrophil percentage, troponin concentration, heart rate, and Charlson Comorbidity Index. The model demonstrated strong discriminatory ability, with C-statistic values of 0.80 in the derivation cohort, 0.79 in the internal validation cohort, and 0.76 in the external validation cohort.
Conclusion
The validated prediction model provides accurate estimation of SICM risk. Based on routinely available clinical variables, the model has potential utility for early risk stratification and individualized management of patients with sepsis, supporting improved clinical outcomes in those at elevated risk of SICM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care Unit, Affiliated Hospital of Hebei University, Baoding City, China.
- Department of Medical Clinic, Tangshan College, Tangshan City, China.
Zitieren
APA
Shao, T., Su, D., Zhang, J., Kan, W., Wang, Y., Wu, J., Zhang, N., Cui, N., & Zhang, H. (2026). Development and validation of a clinical prediction model for sepsis-induced cardiomyopathy. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1788162
Vancouver
Shao T, Su D, Zhang J, Kan W, Wang Y, Wu J, et al. Development and validation of a clinical prediction model for sepsis-induced cardiomyopathy. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1788162
BibTeX
@article{Shao2026,
author = {Shao, Tenghao and Su, Dan and Zhang, Jinwen and Kan, Wenchao and Wang, Yingxin and Wu, Jiaqian and Zhang, Nan and Cui, Na and Zhang, Hongwei},
title = {Development and validation of a clinical prediction model for sepsis-induced cardiomyopathy},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1788162}
}
EUVIMED